Avalo Therapeutics, Inc. (AVTX)
19.59
-0.46
(-2.29%)
USD |
NASDAQ |
Aug 28, 16:00
19.60
+0.01
(+0.05%)
After-Hours: 20:00
Avalo Therapeutics Free Cash Flow : -68.29M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -68.29M |
| March 31, 2026 | -59.69M |
| December 31, 2025 | -51.46M |
| September 30, 2025 | -52.26M |
| June 30, 2025 | -47.42M |
| March 31, 2025 | -52.31M |
| December 31, 2024 | -49.06M |
| September 30, 2024 | -36.94M |
| June 30, 2024 | -32.24M |
| March 31, 2024 | -26.99M |
| December 31, 2023 | -30.84M |
| September 30, 2023 | -31.85M |
| June 30, 2023 | -19.33M |
| March 31, 2023 | -20.83M |
| December 31, 2022 | -26.85M |
| September 30, 2022 | -40.02M |
| June 30, 2022 | -62.07M |
| March 31, 2022 | -68.74M |
| December 31, 2021 | -71.00M |
| September 30, 2021 | -68.27M |
| June 30, 2021 | -63.83M |
| Date | Value |
|---|---|
| March 31, 2021 | -53.20M |
| December 31, 2020 | -40.60M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| September 30, 2019 | -20.19M |
| June 30, 2019 | -13.15M |
| March 31, 2019 | -6.680M |
| December 31, 2018 | -3.692M |
| September 30, 2018 | -3.782M |
| June 30, 2018 | 15.91M |
| March 31, 2018 | 14.49M |
| December 31, 2017 | 12.56M |
| September 30, 2017 | 11.33M |
| June 30, 2017 | -11.14M |
| March 31, 2017 | -13.12M |
| December 31, 2016 | -14.59M |
| September 30, 2016 | -14.41M |
| June 30, 2016 | -12.91M |
| March 31, 2016 | -10.86M |
| December 31, 2015 | -10.28M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Incyte Corp. | 1.890B |
| AbbVie, Inc. | 18.21B |
| Rezolute, Inc. | -73.48M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.99M |
| Cash from Investing (Quarterly) | -329.92M |
| Cash from Financing (Quarterly) | 410.21M |
| Free Cash Flow Per Share (Quarterly) | -0.4584 |
| Free Cash Flow to Equity (Quarterly) | -19.90M |
| Free Cash Flow to Firm (Quarterly) | -19.99M |
| Free Cash Flow Yield | -14.49% |